Kris Movig

Department of Clinical Pharmacy, Medisch Spectrum Twente, Enschede, the Netherlands, Netherlands

I do not have any relevant financial / non-financial relationships with any proprietary interests.

Presentation(s):

• Discontinuation of Infliximab Treatment in IBD Patients: A Comparison Between Patients Who Retransitioned to Originator and Those Who Remained on Biosimilar

  Saturday, August 27, 2022
  1:45 PM – 1:50 PM CEST